Loss of P53 facilitates invasion and metastasis of prostate cancer cells

Molecular and Cellular Biochemistry

Volumn 384, Issue 1-2, 2013, Pages 121-127

  Wang, Yi ^a   Zhang, Y X ^a   Kong, C Z ^a   Zhang, Z ^a   Zhu, Y Y ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

EMT; Invasion; Metastasis; P53; Prostate cancer cells

Indexed keywords

CORTACTIN; CYTOSKELETON PROTEIN; FOCAL ADHESION KINASE; GELATIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE; PAXILLIN; PROTEIN P53; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE LOSS; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; METASTASIS; PROSTATE CANCER; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR INVASION; WESTERN BLOTTING; ZYMOGRAPHY;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CORTACTIN; CYTOSKELETON; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION KINASE 1; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PAXILLIN; PHOSPHORYLATION; PROSTATIC NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; TUMOR SUPPRESSOR PROTEIN P53; WOUND HEALING;

EID: 84889098657     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1789-1     Document Type: Article

References (25)

1. Atlanta, Ga, Cancer Facts and Figures 2012, American Cancer Society, 2012
2. Orr FW, Sanchez-Sweatman OH, Kostenuik P et al (1995) Tumor-bone interactions in skeletal metastasis. Clin Orthop 312:19-33
3. Mundy GR (1997) Mechansims of bone metastasis. Cancer (Phila.) 80:1546-1556
4. Scalliet P (1996) Carcinoma of the prostate: treatment of bone metastasis. Acta Urol Belg 64:87-90
5. Carter HB, Coffey DS (1990) The prostate: an increasing medical problem. Prostate 16:39-48
6. Murray-Zmijewski F, Slee EA, Lu X (2008) A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 9:702-712
7. Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 173:413-431
8. Muller PA, Vousden KH, Norman JC (2011) p53 and its mutants in tumor cell migration and invasion. J Cell Biol 192:209-218
9. Elgavish A, Wood PA, Pinkert CA et al (2004) Transgenic mouse with human mutant p53 expression in the prostate epithelium. Prostate 61:26-34
10. Olive KP, Tuveson DA, Ruhe ZC et al (2004) Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119:847-860
11. Muller PA, Caswell PT, Doyle B et al (2009) Mutant p53 drives invasion by promoting integrin recycling. Cell 139:1327-1341
12. Gadea G, de Toledo M, Anguille C et al (2007) Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J Cell Biol 178:23-30
13. Roger L, Gadea G, Roux P (2006) Control of cell migration: a tumour suppressor function for p53? Biol Cell 98:141-152
14. Kemp CJ, Donehower LA, Bradley A et al (1993) Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74:813-822
15. Harrington EA, Fanidi A, Evan GI (1994) Oncogenes and cell death. Curr Opin Genet Dev 4:120-129
16. Golubovskaya VM, Finch R, Kweh F et al (2008) p53 regulates FAK expression in human tumor cells. Mol Carcinog 47:373-382
17. Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18:516-523
18. Hernandez-Barrantes S, Toth M, Bernardo MM et al (2000) Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem 275:12080-12089
19. M Margarida Bernardo and Rafael Fridman (2003) TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochem J 374:739-745
20. Lin S, Yu L, Yang J et al (2011) Mutant p53 disrupts role of ShcA protein in balancing Smad protein-dependent and -independent signaling activity of transforming growth factor-β (TGF-β). J Biol Chem 286:44023-44034
21. Schlaepfer DD, Mitra SK (2004) Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 14:92-101
22. Parsons JT (2003) Focal adhesion kinase: the first ten years. J Cell Sci 116:1409-1416
23. Harburger DS, Calderwood DA (2009) Integrin signalling at a glance. J Cell Sci 122:159-163
24. Wang W, Liu Y, Liao K (2011) Tyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motility. BMC Cell Biol 12:49
25. Michael DS (2001) Paxillin: a focal adhesion-associated adaptor protein. Oncogene 20:6459-6472